Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-04-01
2008-04-01
Kwon, Brian (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
10734586
ABSTRACT:
Method of producing a physiologically acceptable ketosis such as to treat a patient in need of therapy for one or more of Amylotrophic lateral sclerosis, Free Radical disease, Heart failure and Duchenne's muscular dystrophy by oral administration to the patient of a cyclic oligomer of formula (I)where n is an integer of 1 or more or a complex thereof with one or more cations or a salt thereof, wherein the physiologically acceptable ketosis is characterized by blood levels of (R)-3-hydroxybutyrate of from 0.5 to 20 mM.
REFERENCES:
patent: 5286842 (1994-02-01), Kimura
patent: 6136862 (2000-10-01), Hiraide et al.
patent: 6207217 (2001-03-01), Peoples et al.
patent: 6323237 (2001-11-01), Veech
patent: 6380244 (2002-04-01), Martin et al.
patent: 2004/0266872 (2004-12-01), Veech
patent: 0780123 (1997-06-01), None
patent: 00/04895 (2000-02-01), None
“Heart Failure Ketosis”, Lommi et al., Journal of Internal Medicine, 1997, vol. 242, pp. 231-238.
“Ketosis and Cardiac Failure: Common Signs of a Single Condition”, Diltoer et al., European Journal of Emergency Medicine, abstract, 11(3):172-175, 2004.
BTG International Limited
Kwon Brian
Nixon & Vanderhye
LandOfFree
Therapeutic compositions (II) does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic compositions (II), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic compositions (II) will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3904186